Spots Global Cancer Trial Database for optic nerve glioma
Every month we try and update this database with for optic nerve glioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma | NCT02839720 | Cutaneous Neuro... Neurofibromatos... Optic Nerve Gli... | Laboratory Biom... Selumetinib Sul... | 18 Years - | National Cancer Institute (NCI) | |
| A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas | NCT01837862 | Pilomyxoid Astr... Pilocytic Astro... Glioma, Astrocy... Optic Nerve Gli... Pleomorphic Xan... Glioblastoma Mu... Anaplastic Astr... Gliosarcoma Diffuse Intrins... DIPG Low-grade Gliom... Brainstem Gliom... | Mebendazole Vincristine Carboplatin Temozolomide Bevacizumab Irinotecan | 1 Year - 21 Years | Northwell Health | |
| Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma | NCT01260103 | Optic Nerve Gli... | Temozolomide ANP Therapy | 6 Months - 18 Years | Burzynski Research Institute | |
| Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology | NCT04648462 | Astrocytoma Ependymoma Ganglioglioma Oligodendroglio... Optic Nerve Gli... Meningioma Nerve Sheath Ne... Adenoma Craniopharyngio... Hemangiopericyt... Germinoma Neurilemmoma | ProTRAIT | 18 Years - | Maastricht Radiation Oncology | |
| Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma | NCT02839720 | Cutaneous Neuro... Neurofibromatos... Optic Nerve Gli... | Laboratory Biom... Selumetinib Sul... | 18 Years - | National Cancer Institute (NCI) | |
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | NCT01966809 | Brain Tumor, Re... | Photofrin photo... | 18 Years - | Medical College of Wisconsin | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Phase 3 Study of ANP Therapy vs. TMZ for Optic Pathway Glioma | NCT01260103 | Optic Nerve Gli... | Temozolomide ANP Therapy | 6 Months - 18 Years | Burzynski Research Institute | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours | NCT03326388 | Neurofibromatos... Plexiform Neuro... Optic Nerve Gli... | Selumetinib | 3 Years - 18 Years | Great Ormond Street Hospital for Children NHS Foundation Trust | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology | NCT04648462 | Astrocytoma Ependymoma Ganglioglioma Oligodendroglio... Optic Nerve Gli... Meningioma Nerve Sheath Ne... Adenoma Craniopharyngio... Hemangiopericyt... Germinoma Neurilemmoma | ProTRAIT | 18 Years - | Maastricht Radiation Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
